Exchange: NASDAQ·Updated 04:10 PM EDT
CV logo

CV Central Vermont Public Service Corp.

$5.99
$0.02
(0.34%)
Today
Closed $5.99
$0.00
(0.00%)
After Hours
Reported EarningsAug 13
Mkt Cap$298.78M
Vol38,501.00

About CV

CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.
53

Neutral Sentiment

How do you feel about CV?

Advertisement|Remove ads.